No ratings currently available, see text in Ratings section
below for explanation.
UR Medicine Faculty
The University of Rochester Medical Faculty Group
(URMFG) consists of over 900 specialist and primary care providers spanning 19
departments.
URMFG is certified by the National Committee for Quality Assurance.
Accountable Health Partner
Accountable Health Partners (AHP) is a network of
over 2,000 community and UR medical faculty and a dozen leading hospitals throughout the
region. AHP offers a full range of care.
Dr. Ruth O'Regan, M.D., is the Chair of Medicine and Charles A. Dewey Professor at the University of Rochester. She additionally serves as Physician-in-Chief of Strong Memorial Hospital and as Associate Director of Education and Mentoring at the Wilmot Cancer Institute at University of Rochester....
Dr. Ruth O'Regan, M.D., is the Chair of Medicine and Charles A. Dewey Professor at the University of Rochester. She additionally serves as Physician-in-Chief of Strong Memorial Hospital and as Associate Director of Education and Mentoring at the Wilmot Cancer Institute at University of Rochester.
She previously was Division Chief of Hematology, Medical Oncology and Palliative Care in the Department of Medicine and as Deputy Director at the Carbone Cancer Center at the University of Wisconsin School of Medicine and Public Health (UWSMPH). She served as Chief Scientific officer of the Big Ten Cancer Research Consortium guiding the research and scientific mission of the consortium and as Vice-Chair of the National Comprehensive Cancer Network Board of Directors. Prior to joining the faculty at UWSMPH she was Director of the Glenn Family Breast Cancer Program at the Winship Cancer Institute and as Vice-Chair for Education and Director of the Hematology Oncology Fellowship program in the Department of Hematology and Medical Oncology at Emory University. She additionally served as Chief of Hematology and Medical Oncology at the Georgia Cancer Center for Excellence at Grady Memorial Hospital.
Dr. O'Regan earned her Medical Degree from University College, Dublin, Ireland and completed her Internal Medicine residency at the Medical College of Wisconsin and her Hematology/Oncology fellowship at Northwestern University.
Her research program focuses on identifying mechanisms of resistance to breast-cancer therapies and on the development of new therapies with a specific focus on triple negative breast cancer.
Certified Specialties
Medical Oncology
- American Board of Internal Medicine
Faculty Appointments
Professor
-
Department of Medicine (SMD)
Chair
-
Department of Medicine (SMD)
Charles Ayrault Dewey Professorship of Medicine
-
Department of Medicine (SMD)
Patient will be treated with neratinib, an aromatase inhibitor and trastuzumab for 24 weeks prior to surgery, following an initial 3 weeks of neratinib alone, aromatase inhibitor alone or the combination of neratinib and an aromatase inhibitor. A bre...
This is an open label, multi-institutional, single arm phase II trial of ribociclib in combination with bicalutamide in advanced AR+ triple-negative breast cancer. No randomization or blinding is involved.
Lin NU, Borges V, Anders C, Murthy RK, Paplomata E, Hamilton E, Hurvitz S, Loi S, Okines A, Abramson V, Bedard PL, Oliveira M, Mueller V, Zelnak A, DiGiovanna MP, Bachelot T, Chien AJ, O'Regan R, Wardley A, Conlin A, Cameron D, Carey L, Curigliano G, Gelmon K, Loibl S, Mayor J, McGoldrick S, An X, Winer EP
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2020 August 1038 (23):2610-2619. Epub 05/29/2020.
Hennes ER, Reed M, Mably M, Jared J, Bergsbaken JJ, Deming D, Callander N, O'Regan R
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.. 2020 July 2377 (15):1243-1248. Epub 1900 01 01.
Di Leo A, Johnston S, Lee KS, Ciruelos E, Lønning PE, Janni W, O'Regan R, Mouret-Reynier MA, Kalev D, Egle D, Cs?szi T, Bordonaro R, Decker T, Tjan-Heijnen VCG, Blau S, Schirone A, Weber D, El-Hashimy M, Dharan B, Sellami D, Bachelot T
The Lancet. Oncology.. 2018 January 19 (1):87-100. Epub 12/07/2017.
André F, Hurvitz S, Fasolo A, Tseng LM, Jerusalem G, Wilks S, O'Regan R, Isaacs C, Toi M, Burris H, He W, Robinson D, Riester M, Taran T, Chen D, Slamon D
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2016 June 2034 (18):2115-24. Epub 04/18/2016.
Taliaferro-Smith L, Oberlick E, Liu T, McGlothen T, Alcaide T, Tobin R, Donnelly S, Commander R, Kline E, Nagaraju GP, Havel L, Marcus A, Nahta R, O'Regan R
Oncotarget.. 2015 March 106 (7):4757-72. Epub 1900 01 01.
André F, O'Regan R, Ozguroglu M, Toi M, Xu B, Jerusalem G, Masuda N, Wilks S, Arena F, Isaacs C, Yap YS, Papai Z, Lang I, Armstrong A, Lerzo G, White M, Shen K, Litton J, Chen D, Zhang Y, Ali S, Taran T, Gianni L
The Lancet. Oncology.. 2014 May 15 (6):580-91. Epub 04/14/2014.
Hurvitz SA, Dalenc F, Campone M, O'Regan RM, Tjan-Heijnen VC, Gligorov J, Llombart A, Jhangiani H, Mirshahidi HR, Tan-Chiu E, Miao S, El-Hashimy M, Lincy J, Taran T, Soria JC, Sahmoud T, André F
Breast cancer research and treatment.. 2013 October 141 (3):437-46. Epub 10/08/2013.
Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society.. 2005 2006 :714-6. Epub 1900 01 01.
O'Regan RM, Gajdos C, Dardes RC, De Los Reyes A, Park W, Rademaker AW, Jordan VC
Journal of the National Cancer Institute.. 2002 February 2094 (4):274-83. Epub 1900 01 01.
Ratings & Comments
At URMC, we believe that patients should be empowered to make the right decisions regarding their
personal
healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all
aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying
star ratings for our providers along with anonymous patient comments on our website. This will help you make
better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used
to generate this vital information. Learn more about
our survey process.
